Global trends and future directions in COVID-19 and leukemia research from 2020 to 2024
This bibliometric analysis indicates that COVID-19 has transformed leukemia research, moving from broad immunocompromised patient strategies to precision medicine integrating infection risk. The established knowledge base and international collaboration provide a solid foundation for future infectious disease challenges in vulnerable cancer populations.
Authors
- Zelin Yang (ORCID: https://orcid.org/0000-0002-7484-8384)
- Jie Tian (ORCID: https://orcid.org/0000-0002-1042-4590)
- Hui Zhao (ORCID: https://orcid.org/0000-0003-0576-1012)
Institutions
- Xi'an Honghui Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1007/s12672-025-04072-z
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00